Limitations on Exercise. Any term or provision hereof to the contrary notwithstanding, the Company shall not effect the exercise of this Warrant, and no Holder shall have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would beneficially own in excess of 9.99% (the “Maximum Percentage”) of the Company’s common stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates (including, without limitation, any convertible notes or convertible shares or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act of 1934 (defined below). For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stock, a Holder of this Warrant may rely on the number of outstanding shares of common stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding.
Appears in 11 contracts
Sources: Credit Agreement (Sonendo, Inc.), Warrant Agreement (Sonendo, Inc.), Warrant Agreement (Sonendo, Inc.)
Limitations on Exercise. Any term or provision hereof Notwithstanding anything to the contrary notwithstandingherein, the Company shall not effect the exercise of this Warrant, and no the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliatesAffiliates) would beneficially own in excess of 9.999.9% (the “Maximum Percentage”) of the Company’s common stock shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock Common Stock beneficially owned by such Person and its affiliates Affiliates shall include the number of shares of such common stock Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates Affiliates (including, without limitation, any convertible notes or convertible shares shares, options or warrants) that is subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934 (defined below)1934, as amended. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in the most recent of (1) the Company’s most recent Form 10-KQ, Form 10-Q K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon the written or oral request of a the Holder, the Company shall within two (2) Business Trading Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified in such notice; provided that (i) any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder. The provisions of this paragraph shall be construed, corrected and implemented in a manner so as to effectuate the intended beneficial ownership limitation herein contained. The limitations contained in this paragraph shall apply to any successor Holder of this Warrant.
Appears in 3 contracts
Sources: Common Stock Purchase Warrant Amendment (Oramed Pharmaceuticals Inc.), Securities Agreement (Oramed Pharmaceuticals Inc.), Securities Agreement (Oramed Pharmaceuticals Inc.)
Limitations on Exercise. Any term or provision hereof Subject to the contrary notwithstandinglast sentence of this Subsection 1(e), the Company shall not effect the exercise of this Warrant, and no the Registered Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person Registered Holder (together with such PersonRegistered Holder’s affiliatesAffiliates and any other Persons acting as a group together) would beneficially own in excess of 9.999.999% (the “Maximum Percentage”) of the Company’s common stock shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock Common Stock beneficially owned by such Person and its affiliates Affiliates shall include the number of shares of such common stock Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates Affiliates (including, without limitation, any convertible notes or convertible shares preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act of 1934 (defined below). For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Registered Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in (1) the Company’s most recent Form 10-K, Proxy Statement, Form 10-Q Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its the Company’s transfer agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon the written or oral request of a the Registered Holder, where such request indicates that it is being made pursuant to this Warrant, the Company shall within two one (21) Business Days Trading Day confirm orally and in writing to the Registered Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including the Warrants, by the Registered Holder and its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. Upon delivery of a written notice to the Company, the Registered Holder may from time to time increase or decrease the Maximum Percentage to any other percentage as specified in such notice; provided that in no event shall such Maximum Percentage be increased to more than 19.99%; provided, further, that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Registered Holder and not to any other holder of Warrants. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Registered Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Subsection 1(e) to the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Subsection 1(e) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations set forth in this Subsection 1(e) shall not apply to exercises of this Warrant that occur prior to and expressly in connection with the Company’s consummation of a Fundamental Transaction.
Appears in 2 contracts
Sources: Warrant Agreement (Ayala Pharmaceuticals, Inc.), Warrant Agreement (Ayala Pharmaceuticals, Inc.)
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the any exercise of this Warrant, and no the Holder shall have the right not be entitled to exercise this WarrantWarrant for a number of the Warrant Shares in excess of that number of the Warrant Shares which, to the extent that after upon giving effect or immediately prior to such exercise, such Person would cause (together i) the aggregate number of shares of the Common Stock beneficially owned by the Holder, its Affiliates and any other Persons whose beneficial ownership of the Common Stock would be aggregated with such Personthe Holder’s affiliatesfor purposes of Section 13(d) would beneficially own in excess of 9.99the Exchange Act to exceed 4.99% (the “Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect to shares of the Common Stock of the Company following such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and or (ii) exercise or conversion the combined voting power of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person the Holder and its affiliates (including, without limitation, Affiliates and any convertible notes or convertible shares or warrants) subject to a limitation on conversion or exercise analogous to other Persons whose beneficial ownership of the limitation contained herein. Except as set forth in Common Stock would be aggregated with the preceding sentence, Holder’s for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act to exceed 4.99% of 1934 (defined below)the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockthe Common Stock, a the Holder of this Warrant may rely on the number of outstanding shares of common stock the Common Stock as reflected in (1x) the Company’s most recent Form 10-K, Q or Form 10-Q or other public filing with the Securities and Exchange CommissionK, as the case may be, filed with the Commission prior to the date hereof, (2y) a more recent public announcement by the Company or (3z) any other notice by the Company or its transfer agent the Transfer Agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon Upon the written or oral request of a the Holder, the Company shall within two three (23) Business Trading Days confirm in writing or by electronic mail to the Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of the Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding shares of the Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 11(a), the aggregate number of shares of the Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of the Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act shall include the shares of the Common Stock issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of the Common Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time shares of the Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of the Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of the Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act.
(b) This Section 11 shall not restrict the number of shares of the Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9(c) of this Warrant.
Appears in 2 contracts
Sources: Security Agreement (NEUROONE MEDICAL TECHNOLOGIES Corp), Security Agreement (NEUROONE MEDICAL TECHNOLOGIES Corp)
Limitations on Exercise. Any term or provision hereof to the contrary notwithstanding, the The Company shall not effect the exercise of this Warrant, and no Holder shall have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would beneficially own in excess of 9.99% (the “Maximum Percentage”) of the Company’s common stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates (including, without limitation, any convertible notes or convertible shares or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934 1934, as amended (defined belowthe “Exchange Act”). For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stock, a Holder of this Warrant may rely on the number of outstanding shares of common stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding.
Appears in 1 contract
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the any exercise of this Warrant, and no the Holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant Shares in excess of that number of Warrant Shares which, to the extent that immediately after giving effect to such exercise, such Person would cause (together with such Person’s affiliatesi) would beneficially own in excess of 9.99% (the “Maximum Percentage”) of the Company’s common stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock Common Shares beneficially owned by the Holder, its Affiliates and any other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such Person and its affiliates shall include as any other members of a Section 13(d) “group”) to exceed [4.99/9.99]% of the total number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise issued and outstanding Common Shares of the remainingCompany following such exercise, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and or (ii) exercise or conversion the combined voting power of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person the Holder and its affiliates (including, without limitation, Affiliates and any convertible notes or convertible shares or warrants) subject to a limitation on conversion or exercise analogous to other Persons whose beneficial ownership of Common Shares would be aggregated with the limitation contained herein. Except as set forth in the preceding sentence, Holder’s for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act (such as any other members of 1934 a Section 13(d) “group”) to exceed [4.99/9.99]% of the combined voting power of all of the securities of the Company then outstanding following such exercise (defined belowthe thresholds in clauses (i) and (ii) each representing the “Maximum Percentage”). For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Shares, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Shares as reflected in (1x) the Company’s most recent Form 1040-F, Form 6-K, Form 10-K, Form 10- Q or other public filing with the Securities and Exchange CommissionForm 8-K, as the case may be, filed with the Commission prior to the date hereof, (2y) a more recent public announcement by the Company or (3z) any other notice by the Company or its transfer agent the Transfer Agent setting forth the number of shares Common Shares outstanding. Upon the written request of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Trading Days confirm in writing or by electronic mail to the Holder the number of shares Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding Common Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% (or, upon the election of the Holder prior to the issuance of the Warrant, 9.99%) as specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 10(a), the aggregate number of Common Shares or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Shares or voting securities would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”) shall include the Common Stock then outstandingShares issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time Common Shares, including without limitation any debt, preferred share, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of Common Shares or voting securities would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”). For purposes of clarity, the Warrant Shares issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) of the Exchange Act or Rule 16a-1(a)(1) promulgated under the Exchange Act.
Appears in 1 contract
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingherein, the Company shall not effect the any exercise of this Warrant, and no Holder the holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant ADSs in excess of that number of Warrant ADSs which, to the extent that after upon giving effect or immediately prior to such exercise, such Person would cause (together i) the aggregate number of Ordinary Shares beneficially owned by the Holder, its Affiliates and any Persons who are members of a Section 4873-2715-9305 v.3 13(d) group with such Person’s affiliates) would beneficially own in excess of Holder or its Affiliates to exceed 9.99% (the “‘‘Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect Ordinary Shares of the Company following such exercise, or (ii) the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates to exceed the Maximum Percentage of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this paragraph, beneficial ownership and whether a holder is a member of a Section 13(d) group shall be calculated and determined in accordance with Section 13(d) of the foregoing sentenceExchange Act and the rules promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding Ordinary Shares (including Ordinary Shares underlying outstanding ADSs), the Holder may rely on the number of outstanding Ordinary Shares as reflected in (x) the Company’s most recent Current Report on Form 6-K reporting quarterly financial results of the Company or Annual Report on Form 20-F, as the case may be, filed with the Commission prior to the date hereof, (y) a more recent public announcement by the Company or (z) any other notice by the Company, the transfer agent for the Ordinary Shares or the Depositary setting forth the number of Ordinary Shares outstanding (including Ordinary Shares underlying outstanding ADSs). Upon the written request of the Holder, the Company shall within three (3) Trading Days confirm in writing or by electronic mail to the Holder the number of Ordinary Shares then outstanding (including Ordinary Shares underlying outstanding ADSs). In any case, the number of outstanding Ordinary Shares (including Ordinary Shares underlying outstanding ADSs) shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding Ordinary Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 1l(a), the aggregate number of shares of Company’s common stock Ordinary Shares or voting securities beneficially owned by such Person the Holder and its affiliates Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates shall include the number of shares of such common stock ADSs (and underlying Warrant Shares) issuable upon (x) the exercise of this Warrant with respect to which the such determination of such sentence is being made, but shall exclude shares the number of common stock Warrant ADSs which would be issuable upon (i) exercise of the remaining, remaining unexercised and non-cancelled portion of this Warrant beneficially owned by such Person and its affiliates the Holder and (iiy) the exercise or conversion of the unexercised unexercised, non-converted or unconverted non-cancelled portion of any other securities of the Company beneficially owned by such Person and its affiliates that do not have voting power (includingincluding without limitation any securities of the Company which would entitle the holder thereof to acquire at any time ADSs or Ordinary Shares, including without limitationlimitation any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible notes into or convertible shares exercisable or warrants) exchangeable for, or otherwise entitles the holder thereof to receive, ADSs or Ordinary Shares), is subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in herein and is beneficially owned by the preceding sentence, for purposes Holder or any of this paragraph, beneficial ownership shall be calculated in accordance with its Affiliates and other Persons who are members of a Section 13(d) group with such Holder or its Affiliates.
(b) This Section 11 shall not restrict the number of ADSs which a Holder may receive or beneficially own in order to determine the Exchange Act amount of 1934 (defined below). For purposes securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant, in determining the number of outstanding shares of Company’s common stock, a Holder of this Warrant may rely on the number of outstanding shares of common stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding.
Appears in 1 contract
Sources: Warrant Agreement (Mesoblast LTD)
Limitations on Exercise. Any term or provision hereof (i) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the exercise of any portion of this Warrant, and no the Holder shall not have the right to exercise any portion of this Warrant, and any such exercise shall be null and void and treated as if never made, to the extent that after giving effect to such exercise, such Person (the Holder together with such Person’s affiliates) the other Attribution Parties collectively would beneficially own in excess of 9.99% (the “Maximum Percentage”) of the Company’s common stock shares of Common Stock outstanding immediately after giving effect to such exercise. Notwithstanding anything to the contrary set forth herein, by written notice to the Company, the Holder may, in its sole discretion, increase or decrease the Maximum Percentage to any other percentage not in excess of 19.999% of the Common Stock of the Company issued and outstanding on June 16, 2022 (when taken together with any shares issued pursuant to this Warrant unless the Company’s shareholders shall have approved the transactions contemplated by this Warrant) specified in such notice and such percentage will be deemed the new Maximum Percentage for all purposes under this Warrant; provided, that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of the foregoing sentencepreceding sentences, the aggregate number of shares of Company’s common stock Common Stock beneficially owned by such Person the Holder and its affiliates the other Attribution Parties shall include the number of shares of such common stock Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock Common Stock which would be issuable upon (iA) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates the Holder or any of the other Attribution Parties and (iiB) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates (including, without limitation, any convertible notes or convertible shares preferred stock or warrants, including other warrants issued concurrently herewith) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained hereinin this Section 1(d). Except as set forth in the preceding sentence, for For purposes of this paragraphSection 1(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act of 1934 (defined below)Act. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stock, a Common Stock the Holder may acquire upon the exercise of this Warrant may rely without exceeding the Maximum Percentage, there were 162,771,033 shares of Common Stock issued and outstanding as of the issuance of this Warrant on June 16, 2022.
(ii) Additionally, the Holder shall not be entitled to exercise this Warrant for a number of outstanding shares Warrant Shares in excess of common stock as reflected that number of Warrant Shares which, upon giving effect to such exercise, would result any required filing and clearance under the ▇▇▇▇-▇▇▇▇▇-▇▇▇▇▇▇ Antitrust Improvements Act (the “HSR Act”) if one has not been made and pre-approval obtained. If a filing and clearance under the HSR Act would be required in (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing connection with the Securities exercise of this Warrant, the Holder and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or shall make such filings promptly and to seek early termination, and only exercise such Warrants after applicable approvals are obtained.
(3iii) any other notice by If the Company receives an Exercise Notice from the Holder at a time when the when the issuance of the Warrant Shares would not comply with applicable law, including the rules and regulations of the New York Stock Exchange (the “NYSE”) (or its transfer agent setting forth any securities exchange on which the Common Stock is listed) (“Applicable Law”), the Company shall (A) notify the Holder in writing of the number of shares of Common Stock issued or issuable in connection with any other transaction by the CompanyCompany that may be aggregated with the issuance of the Warrant Shares under the rules and regulations of the NYSE (or any other securities exchange on which the Common Stock is then listed), and to the extent that such Exercise Notice would otherwise cause the Holder’s common stock outstanding. For beneficial ownership, as determined pursuant to this Section 1(d), to exceed the Maximum Percentage or would not comply with Applicable Law, the Holder must notify the Company of a reduced number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the “Reduction Shares”) and (B) as soon as reasonably practicable, the Company shall return to the Holder any reason at any time, upon Exercise Price paid by the Holder for the Reduction Shares.
(vi) Upon the written or oral request of a the Holder, the Company shall within two (2) Business Days promptly confirm in writing or by electronic mail to the Holder the number of shares of the Company’s Common Stock issued or issuable in connection with any other transaction by the Company that may be aggregated with the issuance of the Warrant Shares under the rules and regulations of the NYSE (or any other securities exchange on which the Common Stock is then outstandinglisted).
(v) For purposes of clarity, (A) the shares of Class A Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage or the issuance of which would not comply with Applicable Law shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act.
(vi) No prior inability to exercise this Warrant pursuant to this Section 1(d) shall have any effect on the applicability of the provisions of this Section 1(d) with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(d) to the extent necessary to correct this paragraph or any portion of this Section 1(d) which may be defective or inconsistent with the intended beneficial ownership or Applicable Law limitation contained in this Section 1(d) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this Section 1(d) may not be waived and shall apply to a successor holder of this Warrant.
(vii) For purposes of Rule 144 promulgated under the Securities Act of 1933, as amended, it is intended, understood and acknowledged that the Warrant Shares issued in a Cashless Exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the U.S. Securities and Exchange Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a Cashless Exercise, as set forth in this Section 1.
Appears in 1 contract
Sources: Warrant Agreement (Grove Collaborative Holdings, Inc.)
Limitations on Exercise. Any term or provision hereof to the contrary notwithstanding, the The Company shall not effect the exercise of this Warrant, and no the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would beneficially own in excess of 9.994.99% (the “Maximum Percentage”) of the Company’s common stock Common Shares outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock Common Shares beneficially owned by such Person and its affiliates shall include the number of shares of such common stock Common Shares issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock Common Shares which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates (including, without limitation, any convertible notes or convertible shares or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934 1934, as amended (defined belowthe “Exchange Act”). For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Shares, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Shares as reflected in the most recent of (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent the Transfer Agent setting forth the number of shares of the Company’s common stock Common Shares outstanding. For any reason at any time, upon the written or oral request of a the Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company’s , including this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding Common Stock then outstandingShares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 19.99% specified in such notice; provided that (i) any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder. The provisions of this paragraph shall be construed, corrected and implemented in a manner so as to effectuate the intended beneficial ownership limitation herein contained. The limitations contained in this paragraph shall apply to any successor Holder of this Warrant.
Appears in 1 contract
Sources: Warrant Agreement (LIGHTBRIDGE Corp)
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingherein, the Company shall not effect the any exercise of this Warrant, and no Holder the holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant ADSs in excess of that number of Warrant ADSs which, to the extent that after upon giving effect or immediately prior to such exercise, such Person would cause (together i) the aggregate number of Ordinary Shares beneficially owned by the Holder, its Affiliates and any Persons who are members of a Section 13(d) group with such Person’s affiliates) would beneficially own in excess of Holder or its Affiliates to exceed 9.99% (the “‘‘Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect Ordinary Shares of the Company following such exercise, or (ii) the combined voting power of the securities of the Company beneficially owned 4846-2431-8974 v.13 by the Holder and its Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates to exceed the Maximum Percentage of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this paragraph, beneficial ownership and whether a holder is a member of a Section 13(d) group shall be calculated and determined in accordance with Section 13(d) of the foregoing sentenceExchange Act and the rules promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding Ordinary Shares (including Ordinary Shares underlying outstanding ADSs), the Holder may rely on the number of outstanding Ordinary Shares as reflected in (x) the Company’s most recent Current Report on Form 6-K reporting quarterly financial results of the Company or Annual Report on Form 20-F, as the case may be, filed with the Commission prior to the date hereof, (y) a more recent public announcement by the Company or (z) any other notice by the Company, the transfer agent for the Ordinary Shares or the Depositary setting forth the number of Ordinary Shares outstanding (including Ordinary Shares underlying outstanding ADSs). Upon the written request of the Holder, the Company shall within three (3) Trading Days confirm in writing or by electronic mail to the Holder the number of Ordinary Shares then outstanding (including Ordinary Shares underlying outstanding ADSs). In any case, the number of outstanding Ordinary Shares (including Ordinary Shares underlying outstanding ADSs) shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding Ordinary Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 1l(a), the aggregate number of shares of Company’s common stock Ordinary Shares or voting securities beneficially owned by such Person the Holder and its affiliates Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates shall include the number of shares of such common stock ADSs (and underlying Warrant Shares) issuable upon (x) the exercise of this Warrant with respect to which the such determination of such sentence is being made, but shall exclude shares the number of common stock Warrant ADSs which would be issuable upon (i) exercise of the remaining, remaining unexercised and non-cancelled portion of this Warrant beneficially owned by such Person and its affiliates the Holder and (iiy) the exercise or conversion of the unexercised unexercised, non-converted or unconverted non-cancelled portion of any other securities of the Company beneficially owned by such Person and its affiliates that do not have voting power (includingincluding without limitation any securities of the Company which would entitle the holder thereof to acquire at any time ADSs or Ordinary Shares, including without limitationlimitation any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible notes into or convertible shares exercisable or warrants) exchangeable for, or otherwise entitles the holder thereof to receive, ADSs or Ordinary Shares), is subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in herein and is beneficially owned by the preceding sentence, for purposes Holder or any of this paragraph, beneficial ownership shall be calculated in accordance with its Affiliates and other Persons who are members of a Section 13(d) group with such Holder or its Affiliates.
(b) This Section 11 shall not restrict the number of ADSs which a Holder may receive or beneficially own in order to determine the Exchange Act amount of 1934 (defined below). For purposes securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant, in determining the number of outstanding shares of Company’s common stock, a Holder of this Warrant may rely on the number of outstanding shares of common stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding.
Appears in 1 contract
Sources: Warrant Agreement (Mesoblast LTD)
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the any exercise of this Warrant, and no the Holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant Shares in excess of that number of Warrant Shares which, to the extent that after upon giving effect or immediately prior to such exercise, would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such Person (together with such Person’s affiliatesas any other members of a Section 13(d) would beneficially own in excess of “group”), to exceed 9.99% (the “Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect to shares of Common Stock of the Company following such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and or (ii) exercise or conversion the combined voting power of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person the Holder and its affiliates (including, without limitation, Affiliates and any convertible notes or convertible shares or warrants) subject to a limitation on conversion or exercise analogous to other Persons whose beneficial ownership of Common Stock would be aggregated with the limitation contained herein. Except as set forth in the preceding sentence, Holder’s for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act (such as any other members of 1934 (defined below)a Section 13(d) “group”) to exceed 9.99% of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in (1x) the Company’s most recent Form 10-K, Q or Form 10-Q or other public filing with the Securities and Exchange CommissionK, as the case may be, filed with the Commission prior to the date hereof, (2y) a more recent public announcement by the Company or (3z) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding.Stock
Appears in 1 contract
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the any exercise of this Warrant, and no the Holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant Shares in excess of that number of Warrant Shares which, to the extent that after upon giving effect or immediately prior to such exercise, such Person would cause (together i) the aggregate number of shares of Common Stock beneficially owned as calculated in accordance with Section 13(d) of the United States Securities Exchange Act of 1934, as amended, by the Holder, its Affiliates and any Persons who are members of a Section 13(d) group with such Person’s affiliates) would beneficially own in excess of 9.99Holder or its Affiliates to exceed 4.99% (the “Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect to shares of Common Stock of the Company following such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and or (ii) exercise or conversion the combined voting power of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person the Holder and its affiliates (including, without limitation, Affiliates and any convertible notes or convertible shares or warrants) subject to other Persons who are members of a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) group with such Holder or its Affiliates to exceed the Maximum Percentage of the Exchange Act combined voting power of 1934 (defined below)all of the securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in (1x) the Company’s most recent Form 10-K, Quarterly Report on Form 10-Q or other public filing with the Securities and Exchange CommissionAnnual Report on Form 10-K, as the case may be, filed with the Commission prior to the date hereof, (2y) a more recent public announcement by the Company or (3z) any other notice by the Company or its transfer agent the Transfer Agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon Upon the written or oral request of a the Holder, the Company shall within two three (23) Business Trading Days confirm in writing or by electronic mail to the Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice. For purposes of this Section 11(a), the aggregate number of shares of Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates shall include the shares of Common Stock issuable upon (x) the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) the exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons who are members of a Section 13(d) group with such Holder or its Affiliates.
(b) This Section 11 shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant.
Appears in 1 contract
Limitations on Exercise. Any term or provision hereof Subject to the contrary notwithstandinglast sentence of this Section 1(e), the Company shall not effect the exercise of this Warrant, and no the Registered Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person Registered Holder (together with such PersonRegistered Holder’s affiliatesAffiliates and any other Persons acting as a group together) would beneficially own in excess of 9.999.999% (the “Maximum Percentage”) of the Company’s common stock shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock Common Stock beneficially owned by such Person and its affiliates Affiliates shall include the number of shares of such common stock Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates Affiliates (including, without limitation, any convertible notes or convertible shares preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act of 1934 (defined below). For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Registered Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in (1) the Company’s most recent Form 10-K, Proxy Statement, Form 10-Q Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its the Company’s transfer agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon the written or oral request of a the Registered Holder, where such request indicates that it is being made pursuant to this Warrant, the Company shall within two one (21) Business Days Trading Day confirm orally and in writing to the Registered Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including the Warrants, by the Registered Holder and its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. Upon delivery of a written notice to the Company, the Registered Holder may from time to time increase or decrease the Maximum Percentage to any other percentage as specified in such notice; provided that in no event shall such Maximum Percentage be increased to more than 19.99%; provided, further, that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Registered Holder and not to any other holder of Warrants. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Registered Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(e) to the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(e) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations set forth in this Section 1(e) shall not apply to exercises of this Warrant that occur prior to and expressly in connection with the Company’s consummation of a Fundamental Transaction. Unless earlier exercised, this Warrant shall automatically be deemed exercised in accordance with the provisions of Section 1(b) hereof immediately prior to the consummation of a Fundamental Transaction. “Fundamental Transaction” means that (A) the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Person, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company to another Person, or (iii) allow another Person to make a purchase, tender or exchange offer that is accepted by the holders of more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or exchange offer), or (iv) consummate a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock purchase agreement or other business combination) or (B) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the 1934 Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of more than 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.
Appears in 1 contract
Sources: Common Stock Purchase Warrant (Selecta Biosciences Inc)
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the any exercise of this Warrant, and no the Holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant Shares in excess of that number of Warrant Shares which, to the extent that after upon giving effect or immediately prior to such exercise, would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder, its Affiliates and any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such Person (together with such Person’s affiliatesas any other members of a Section 13(d) would beneficially own in excess of 9.99% “group”) to exceed [4.99][9.99]% (the “Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect to shares of Common Stock of the Company following such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and or (ii) exercise or conversion the combined voting power of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person the Holder and its affiliates (including, without limitation, Affiliates and any convertible notes or convertible other Persons whose beneficial ownership of shares or warrants) subject to a limitation on conversion or exercise analogous to of Common Stock would be aggregated with the limitation contained herein. Except as set forth in the preceding sentence, Holder’s for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act (such as any other members of 1934 (defined below)a Section 13(d) “group”) to exceed [4.99][9.99]% of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in (1x) the Company’s most recent Form 10-K, Q or Form 10-Q or other public filing with the Securities and Exchange CommissionK, as the case may be, filed with the Commission prior to the date hereof, (2y) a more recent public announcement by the Company or (3z) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon Upon the written or oral request of a the Holder, the Company shall within two three (23) Business Trading Days confirm in writing or by electronic mail to the Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 11(a), the aggregate number of shares of Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”) shall include the shares of Common Stock issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time shares of Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”).
(b) This Section 11 shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9(c) of this Warrant.
Appears in 1 contract
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingcontained herein, the Company shall not effect the any exercise of this Warrant, and no the Holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant Shares in excess of that number of Warrant Shares which, to the extent that after upon giving effect or immediately prior to such exercise, would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder, its Affiliates and any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such Person (together with such Person’s affiliatesas any other members of a Section 13(d) would beneficially own in excess of “group”), to exceed [4.99%] [9.99% %] (the “Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect to shares of Common Stock of the Company following such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Company’s common stock beneficially owned by such Person and its affiliates shall include the number of shares of such common stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of common stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and or (ii) exercise or conversion the combined voting power of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person the Holder and its affiliates (including, without limitation, Affiliates and any convertible notes or convertible other Persons whose beneficial ownership of shares or warrants) subject to a limitation on conversion or exercise analogous to of Common Stock would be aggregated with the limitation contained herein. Except as set forth in the preceding sentence, Holder’s for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act (such as any other members of 1934 (defined below)a Section 13(d) “group”) to exceed [4.99%] [9.99%] of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding shares of Company’s common stockCommon Stock, a the Holder of this Warrant may rely on the number of outstanding shares of common stock Common Stock as reflected in (1x) the Company’s most recent Form 10-K, Quarterly Report on Form 10-Q or other public filing with the Securities and Exchange CommissionAnnual Report on Form 10-K, as the case may be, filed with the Commission prior to the date hereof, (2y) a more recent public announcement by the Company or (3z) any other notice by the Company or its transfer agent Transfer Agent setting forth the number of shares of the Company’s common stock Common Stock outstanding. For any reason at any time, upon Upon the written or oral request of a the Holder, the Company shall within two (2) Business Trading Days confirm in writing or by electronic mail to the Holder the number of shares of the Company’s Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 11(a), the aggregate number of shares of Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”) shall include the shares of Common Stock issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including, without limitation, any securities of the Company which would entitle the holder thereof to acquire at any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other member of a Section 13(d) “group”).
(b) This Section 11 shall not restrict the number of shares of Common Stock that a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9(c) of this Warrant.
Appears in 1 contract
Sources: Underwriting Agreement (Tarsus Pharmaceuticals, Inc.)
Limitations on Exercise. Any term or provision hereof (a) Notwithstanding anything to the contrary notwithstandingherein, the Company shall not effect the any exercise of this Warrant, and no Holder the holder shall have the right not be entitled to exercise this WarrantWarrant for a number of Warrant ADSs in excess of that number of Warrant ADSs which, to the extent that after upon giving effect or immediately prior to such exercise, such Person would cause (together i) the aggregate number of Ordinary Shares beneficially owned by the Holder, its Affiliates and any Persons who are members of a Section 13(d) group with such Person’s affiliates) would beneficially own in excess of Holder or its Affiliates to exceed 9.99% (the “‘‘Maximum Percentage”) of the Company’s common stock total number of issued and outstanding immediately after giving effect Ordinary Shares of the Company following such exercise, or (ii) the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates to exceed the Maximum Percentage of the combined voting 4853-3746-0046 v.3 power of all of the securities of the Company then outstanding following such exercise. For purposes of this paragraph, beneficial ownership and whether a holder is a member of a Section 13(d) group shall be calculated and determined in accordance with Section 13(d) of the foregoing sentenceExchange Act and the rules promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding Ordinary Shares (including Ordinary Shares underlying outstanding ADSs), the Holder may rely on the number of outstanding Ordinary Shares as reflected in (x) the Company’s most recent Current Report on Form 6-K reporting quarterly financial results of the Company or Annual Report on Form 20-F, as the case may be, filed with the Commission prior to the date hereof, (y) a more recent public announcement by the Company or (z) any other notice by the Company, the transfer agent for the Ordinary Shares or the Depositary setting forth the number of Ordinary Shares outstanding (including Ordinary Shares underlying outstanding ADSs). Upon the written request of the Holder, the Company shall within three (3) Trading Days confirm in writing or by electronic mail to the Holder the number of Ordinary Shares then outstanding (including Ordinary Shares underlying outstanding ADSs). In any case, the number of outstanding Ordinary Shares (including Ordinary Shares underlying outstanding ADSs) shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding Ordinary Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99% specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 1l(a), the aggregate number of shares of Company’s common stock Ordinary Shares or voting securities beneficially owned by such Person the Holder and its affiliates Affiliates and any other Persons who are members of a Section 13(d) group with such Holder or its Affiliates shall include the number of shares of such common stock ADSs (and underlying Warrant Shares) issuable upon (x) the exercise of this Warrant with respect to which the such determination of such sentence is being made, but shall exclude shares the number of common stock Warrant ADSs which would be issuable upon (i) exercise of the remaining, remaining unexercised and non-cancelled portion of this Warrant beneficially owned by such Person and its affiliates the Holder and (iiy) the exercise or conversion of the unexercised unexercised, non-converted or unconverted non-cancelled portion of any other securities of the Company beneficially owned by such Person and its affiliates that do not have voting power (includingincluding without limitation any securities of the Company which would entitle the holder thereof to acquire at any time ADSs or Ordinary Shares, including without limitationlimitation any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible notes into or convertible shares exercisable or warrants) exchangeable for, or otherwise entitles the holder thereof to receive, ADSs or Ordinary Shares), is subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in herein and is beneficially owned by the preceding sentence, for purposes Holder or any of this paragraph, beneficial ownership shall be calculated in accordance with its Affiliates and other Persons who are members of a Section 13(d) group with such Holder or its Affiliates.
(b) This Section 11 shall not restrict the number of ADSs which a Holder may receive or beneficially own in order to determine the Exchange Act amount of 1934 (defined below). For purposes securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant, in determining the number of outstanding shares of Company’s common stock, a Holder of this Warrant may rely on the number of outstanding shares of common stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of the Company’s common stock outstanding. For any reason at any time, upon the written or oral request of a Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of the Company’s Common Stock then outstanding.
Appears in 1 contract
Sources: Warrant Agreement (Mesoblast LTD)